Bulk Manufacturer of Controlled Substances Registration, 34695-34696 [2017-15692]

Download as PDF 34695 Federal Register / Vol. 82, No. 142 / Wednesday, July 26, 2017 / Notices Dated: July 20, 2017. Demetra Ashley, Acting Assistant Administrator. applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before September 25, 2017. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. [FR Doc. 2017–15693 Filed 7–25–17; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] ACTION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and SUPPLEMENTARY INFORMATION: Bulk Manufacturer of Controlled Substances Application: AMRI Rensselaer, Inc. Notice of application. Registered bulk manufacturers of the affected basic classes, and DATES: implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on March 30, 2017, AMRI Rensselaer, Inc., 33 Riverside Avenue, Rensselaer, New York 12144 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: Controlled substance Drug code Marihuana ........................................................................................................................................................................ Tetrahydrocannabinols .................................................................................................................................................... Amphetamine ................................................................................................................................................................... Lisdexamfetamine ............................................................................................................................................................ Methylphenidate .............................................................................................................................................................. Pentobarbital .................................................................................................................................................................... 4-Anilino-N-phenethyl-4-piperidine (ANPP) ..................................................................................................................... Codeine ........................................................................................................................................................................... Oxycodone ....................................................................................................................................................................... Hydromorphone ............................................................................................................................................................... Hydrocodone ................................................................................................................................................................... Meperidine ....................................................................................................................................................................... Morphine .......................................................................................................................................................................... Fentanyl ........................................................................................................................................................................... The company plans to manufacture bulk controlled substances for use in product development and for distribution to its customers. In reference to drug codes 7360 (marihuana) and 7370 (THC), the company plans to bulk manufacture these drugs as synthetics. No other activities for these drug codes are authorized for this registration. Dated: July 19, 2017. Demetra Ashley, Acting Assistant Administrator. [FR Doc. 2017–15688 Filed 7–25–17; 8:45 am] BILLING CODE 4410–09–P Drug Enforcement Administration [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Registration Notice of registration. Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as bulk manufacturers of various classes of controlled substances. SUMMARY: Cedarburg Pharmaceuticals ...................................................................................... Siegfried USA, LLC ................................................................................................... Sigma Aldrich Research Biochemicals, Inc .............................................................. mstockstill on DSK30JT082PROD with NOTICES FR docket 82 FR 19083 ........................................... 82 FR 19084 ........................................... 82 FR 19085 ........................................... VerDate Sep<11>2014 17:49 Jul 25, 2017 Jkt 241001 I I II II II II II II II II II II II II The companies listed below applied to be registered as manufacturers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted for these notices. Company The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of these registrants to manufacture the applicable basic classes of controlled substances is consistent with the public interest and with United States obligations under international 7360 7370 1100 1205 1724 2270 8333 9050 9143 9150 9193 9230 9300 9801 SUPPLEMENTARY INFORMATION: DEPARTMENT OF JUSTICE ACTION: Schedule treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each of the company’s maintenance of effective controls against diversion by inspecting and testing each company’s physical security systems, verifying each PO 00000 Frm 00073 Fmt 4703 Sfmt 4703 Published April 25, 2017. April 25, 2017. April 25, 2017. company’s compliance with state and local laws, and reviewing each company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the DEA has granted a E:\FR\FM\26JYN1.SGM 26JYN1 34696 Federal Register / Vol. 82, No. 142 / Wednesday, July 26, 2017 / Notices Dated: July 19, 2017. Demetra Ashley, Acting Assistant Administrator. registration as a bulk manufacturer to the above listed persons. Dated: July 19, 2017. Demetra Ashley, Acting Assistant Administrator. [FR Doc. 2017–15690 Filed 7–25–17; 8:45 am] BILLING CODE 4410–09–P [FR Doc. 2017–15692 Filed 7–25–17; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration DEPARTMENT OF JUSTICE [Docket No. DEA–392] Drug Enforcement Administration Importer of Controlled Substances Application: AMRI Rensselaer, Inc. [Docket No. DEA–392] ACTION: Bulk Manufacturer of Controlled Substances Application: Organic Consultants, Inc. ACTION: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before September 25, 2017. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. DATES: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on November 2, 2016, Organic Consultants, Inc., 90 North Polk Street, Suite 200, Eugene, Oregon 97402 applied to be registered as a bulk manufacturer for methadone intermediate (9254), a basic class of controlled substance listed in schedule II. The company plans to manufacture analytical reference standards for distribution to its customers for research and analytical purposes. mstockstill on DSK30JT082PROD with NOTICES VerDate Sep<11>2014 17:49 Jul 25, 2017 Jkt 241001 Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before August 25, 2017. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before August 25, 2017. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. Comments and requests for hearings on applications to import narcotic raw material are not appropriate. 72 FR 3417 (January 25, 2007). SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant DATES: Notice of application. SUPPLEMENTARY INFORMATION: Notice of application. PO 00000 Frm 00074 Fmt 4703 Sfmt 4703 Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on June 27, 2016, AMRI Rensselaer, Inc., 33 Riverside Avenue, Rensselaer, New York 12144 applied to be registered as an importer of poppy straw concentrate (9670), a basic class of controlled substance listed in schedule II. The company plans to import the listed controlled substance to manufacture bulk controlled substance for distribution to its customers. Dated: July 20, 2017. Demetra Ashley, Acting Assistant Administrator. [FR Doc. 2017–15689 Filed 7–25–17; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF LABOR Employment and Training Administration Workforce Information Advisory Council Employment and Training Administration, Labor. ACTION: Notice of Renewal of the Workforce Information Advisory Council. AGENCY: The Department of Labor (Department) announces the renewal of the Workforce Information Advisory Council (WIAC) charter. FOR FURTHER INFORMATION CONTACT: Steve Rietzke, Division of National Programs, Tools, and Technical Assistance, Office of Workforce Investment, Rm. C–4510, 200 Constitution Ave. NW., Washington, DC 20212–0001; (202) 693–3912; or use email address for the WIAC, WIAC@ dol.gov. SUMMARY: SUPPLEMENTARY INFORMATION: I. Background and Authority Section 15 of the Wagner-Peyser Act, 29 U.S.C. 49l–2, as amended by section 308 of the Workforce Innovation and Opportunity Act of 2014 (WIOA), Public Law 113–128 requires the Secretary of Labor (Secretary) to establish and maintain the WIAC. The statute, as amended, requires the Secretary, acting through the Commissioner of Labor Statistics and the Assistant Secretary for Employment and Training, to formally consult at least twice annually with the WIAC to address: (1) Evaluation and improvement of the nationwide workforce and labor market information system established by the Wagner- E:\FR\FM\26JYN1.SGM 26JYN1

Agencies

[Federal Register Volume 82, Number 142 (Wednesday, July 26, 2017)]
[Notices]
[Pages 34695-34696]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-15692]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Registrants listed below have applied for and been granted 
registration by the Drug Enforcement Administration (DEA) as bulk 
manufacturers of various classes of controlled substances.

SUPPLEMENTARY INFORMATION: The companies listed below applied to be 
registered as manufacturers of various basic classes of controlled 
substances. Information on previously published notices is listed in 
the table below. No comments or objections were submitted for these 
notices.

------------------------------------------------------------------------
            Company                 FR docket            Published
------------------------------------------------------------------------
Cedarburg Pharmaceuticals.....  82 FR 19083.....  April 25, 2017.
Siegfried USA, LLC............  82 FR 19084.....  April 25, 2017.
Sigma Aldrich Research          82 FR 19085.....  April 25, 2017.
 Biochemicals, Inc.
------------------------------------------------------------------------

    The DEA has considered the factors in 21 U.S.C. 823(a) and 
determined that the registration of these registrants to manufacture 
the applicable basic classes of controlled substances is consistent 
with the public interest and with United States obligations under 
international treaties, conventions, or protocols in effect on May 1, 
1971. The DEA investigated each of the company's maintenance of 
effective controls against diversion by inspecting and testing each 
company's physical security systems, verifying each company's 
compliance with state and local laws, and reviewing each company's 
background and history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the DEA has granted a

[[Page 34696]]

registration as a bulk manufacturer to the above listed persons.

    Dated: July 19, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017-15692 Filed 7-25-17; 8:45 am]
 BILLING CODE 4410-09-P